Patent US5480970A successfully refreshed from Google Patents.
US5480970A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Metal chelators
Assignee: Bracco Suisse SA
•
Filing: 1993-12-22
•
Granted: 1996-01-02
•
Expires: 2013-12-22
Abstract
Abstract Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
Inventors
- 👤 Alfred Pollak
- 👤 Anne Goodbody
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 08:08
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0821; A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/088
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
121 words
A compound of the general formula: ##STR2## wherein R 1 and R 2 together form a 5 - or 6 -membered heterocyclic ring which is optionally fused to a 5- or 6-membered ring, wherein either ring is optionally substituted with a conjugating group or with a conjugating group having a targetting molecule coupled thereto; R 3 is selected from H; alkyl; and alkyl substituted by a group selected from amino, aminoacyl, carboxyl, guanidinyl, hydroxyl, thiol, phenyl, phenolyl, indolyl and imidazolyl; R 4 is selected from hydroxyl; alkoxy; any amino acid residue; and a targetting molecule; and T is H or a sulfur protecting group; with the proviso that R 1 and R 2 do not form a pyridine or pyrrolidine ring.
Claim 2
Dependent Claim
121 words
A compound of the general formula: ##STR2## wherein R 1 and R 2 together form a 5 - or 6 -membered heterocyclic ring which is optionally fused to a 5- or 6-membered ring, wherein either ring is optionally substituted with a conjugating group or with a conjugating group having a targetting molecule coupled thereto; R 3 is selected from H; alkyl; and alkyl substituted by a group selected from amino, aminoacyl, carboxyl, guanidinyl, hydroxyl, thiol, phenyl, phenolyl, indolyl and imidazolyl; R 4 is selected from hydroxyl; alkoxy; any amino acid residue; and a targetting molecule; and T is H or a sulfur protecting group; with the proviso that R 1 and R 2 do not form a pyridine or pyrrolidine ring.
Claim 3
Dependent Claim
22 words
A compound according to claim 1, wherein the ring formed by R 1 and R 2 is a six membered heterocyclic ring.
Claim 4
Dependent Claim
19 words
A compound according to claim 1, wherein R 1 and R 2 together form a 6-carboxy substituted pyridine ring.
Claim 5
Dependent Claim
19 words
A compound according to claim 1, wherein R 1 and R 2 together form a 4-hydroxy-6-carboxy substituted pyridine ring.
Claim 6
Dependent Claim
11 words
A compound according to claim 1 wherein R 3 is H.
Claim 7
Dependent Claim
19 words
A compound according to claim 1, wherein R 3 is the side chain of a serine amino acid residue.
Claim 8
Dependent Claim
42 words
A compound according to claim 1, wherein R 1 and R 2 together form a ring selected from a 6-carboxypyridine ring and a 6-carboxy-4-hydroxypyridine ring; R 3 is a serine amino acid side chain; T is Acm; and R 4 is -Gly-OH.
Claim 9
Dependent Claim
16 words
A compound according to claim 1, wherein R 4 is selected from -Gly-OH and -Gly-targetting molecule.
Claim 10
Dependent Claim
13 words
A compound according to claim 8, wherein the targetting molecule is a peptide.
Claim 11
Dependent Claim
24 words
A compound according to claim 9, wherein the peptide has a sequence selected from: -NH-Lys-Pro-Pro-Arg-OH (SEQ. ID NO: 3) -NH-Thr-Lys-Pro-Pro-Arg-OH (SEQ. ID NO: 2)
Claim 12
Dependent Claim
35 words
A compound according to claim 9, wherein the Gly forms an amide linkage with an ε-amino Lys residue of the peptide selected from: -ε-amino Lys(-Gly-OH)-Tyr-Nleu-Phe-Leu-Nleu-formyl (SEQ. ID NO: 14) -ε-amino Lys(-Asp-Gly-OH)-Lys-Tyr-Nleu-Phe-Leu-Nleu-formyl (SEQ. ID NO: 15).
Claim 13
Dependent Claim
33 words
A compound of the general formula: ##STR3## wherein R 1 and R 2 together form a pyridine ring; R 3 is H; T is Acm; and R 4 is -Gly-ε-amino Lys (-Gly-OH) -Tyr-Nleu-Phe-Leu-Nleu-formyl.
Claim 14
Dependent Claim
33 words
A compound of the general formula: ##STR3## wherein R 1 and R 2 together form a pyridine ring; R 3 is H; T is Acm; and R 4 is -Gly-ε-amino Lys (-Gly-OH) -Tyr-Nleu-Phe-Leu-Nleu-formyl.
Claim 15
Dependent Claim
42 words
A compound of the general formula: ##STR4## wherein R 1 and R 2 together form a pyridine ring; R 3 is a serine amino acid side chain; T is Acm; and R 4 is selected from: -Gly-Lys-Pro-Pro-Arg-OH -Gly-Thr-Lys-Pro-Pro-Arg-OH -Gly-ε-amino Lys(-Gly-OH)-Tyr-Nleu-Phe-Leu-Nleu-formyl -Gly-ε-amino Lys(-Asp-Gly-OH)-Lys-Tyr-Nleu-Phe-Leu-Nleuformyl-formyl.
Claim 16
Dependent Claim
42 words
A compound of the general formula: ##STR4## wherein R 1 and R 2 together form a pyridine ring; R 3 is a serine amino acid side chain; T is Acm; and R 4 is selected from: -Gly-Lys-Pro-Pro-Arg-OH -Gly-Thr-Lys-Pro-Pro-Arg-OH -Gly-ε-amino Lys(-Gly-OH)-Tyr-Nleu-Phe-Leu-Nleu-formyl -Gly-ε-amino Lys(-Asp-Gly-OH)-Lys-Tyr-Nleu-Phe-Leu-Nleuformyl-formyl.
Claim 17
Dependent Claim
130 words
A compound of the general formula: ##STR5## wherein: R 1 and R 2 together form a 5- or 6-membered heterocyclic ring which is optionally fused to a 5- or 6-membered ring, wherein either ring is optionally substituted with a conjugating group or with a conjugating group having a targetting molecule coupled thereto or a hydroxyl group; R 3 is selected from H; alkyl; and alkyl substituted by a group selected from amino, emlnoacyl, carboxyl, guanidinyl, hydroxyl, thiol, phenyl, phenolyl, indolyl end imidazolyl; R 4 selected from hydroxyl; alkoxy; any areinc acid residue; and a targetting molecule; and T is H or a sulfur protecting group; wherein the targetting molecule is a peptide having a sequence: formyl-Nleu-Leu-Phe-Nleu-Tyr-Lys-Lys-Asp-X-OH (SEQ. ID NO: 1) and X is a bond or any amino acid residue.
Claim 18
Dependent Claim
130 words
A compound of the general formula: ##STR5## wherein: R 1 and R 2 together form a 5- or 6-membered heterocyclic ring which is optionally fused to a 5- or 6-membered ring, wherein either ring is optionally substituted with a conjugating group or with a conjugating group having a targetting molecule coupled thereto or a hydroxyl group; R 3 is selected from H; alkyl; and alkyl substituted by a group selected from amino, emlnoacyl, carboxyl, guanidinyl, hydroxyl, thiol, phenyl, phenolyl, indolyl end imidazolyl; R 4 selected from hydroxyl; alkoxy; any areinc acid residue; and a targetting molecule; and T is H or a sulfur protecting group; wherein the targetting molecule is a peptide having a sequence: formyl-Nleu-Leu-Phe-Nleu-Tyr-Lys-Lys-Asp-X-OH (SEQ. ID NO: 1) and X is a bond or any amino acid residue.
Claim 19
Dependent Claim
10 words
A compound according to claim 14, wherein X is -Gly-.
Claim 20
Dependent Claim
13 words
A compound having the formula: ##STR6## wherein X is a bond or -Gly-.
Claim 21
Dependent Claim
13 words
A compound having the formula: ##STR6## wherein X is a bond or -Gly-.
References Cited (Backward Citations)
US4390528A
Cited
US5175343A
Cited
US5187264A
Cited
US5082930A
Cited
US4965392A
Cited
US5091514A
Cited
US5021567A
Cited
US5202451A
Cited
US5202109A
Cited
US5071965A
Cited
EP0352218A2
Cited
US4986979A
Cited
US5196515A
Cited
US5248764A
Cited
US5028593A
Cited
WO1991003200A1
Cited
US5175257A
Cited
US5112595A
Cited
WO1992013572A1
Cited
US5112594A
Cited
WO1992019235A2
Cited
WO1992019274A1
Cited
WO1993010823A1
Cited
US5220000A
Cited
WO1993015770A1
Cited
WO1993017719A1
Cited
WO1993021962A1
Cited
EP0569132A1
Cited
WO1993021957A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-01-01 | 1999-07-03 | 2000-01-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-01-01 | 2003-07-03 | 2004-01-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-01-01 | 2007-07-03 | 2008-01-02 | $7700.00 | Window Closed / Lapsed |